Search - tctmd.com

Displaying 161 - 180 of 767

Sort: Relevancy | Date

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT 2024

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Presenter: William T. Abraham

March 06, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Temperature Controlled Devices

Presenter: Andreas Zuckermann

March 06, 2024

Presentation THT 2024

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Presenter: Maria Rosa Costanzo

March 06, 2024

Presentation THT 2024

Acute and Chronic Outcomes in Early Feasibility Evaluation of Device-Based Thoracic Duct Decompression in Hospitalized Acute Decompensated Heart Failure Patients

Presenter: William T. Abraham

March 06, 2024

Presentation THT 2024

CRT/ICD in LVAD Patients

Presenter: Gabriel Sayer

March 05, 2024

Presentation THT 2024

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Presenter: David M. Kaye

March 05, 2024

Presentation THT 2024

Conduction System Pacing vs CRT in HF

Presenter: Sammy Khatib

March 05, 2024

Presentation THT 2024

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Presenter: Kevin Makati

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Early feasibility study of a prototype device to non-invasively measure cardiac and pulmonary vascular pressures

Presenter: Andrew Sauer

March 05, 2024

Presentation THT Abstracts 2024

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Presenter: Jennifer Cowger

March 05, 2024

Presentation THT Abstracts 2024

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Presenter: John Eisenga

March 05, 2024

Presentation THT 2024

How to Manage VT in Advanced HF and Post-LVAD Patients

Presenter: Jakub Sroubek

March 05, 2024

Presentation THT 2024

Cardiac Contractility Modulation

Presenter: Kanika P. Mody

March 05, 2024

Presentation THT 2024

Overview: Growing Role of EP-HF Collaboration

Presenter: Roderick Tung

March 05, 2024

Advertisement

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Temperature Controlled Devices

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Acute and Chronic Outcomes in Early Feasibility Evaluation of Device-Based Thoracic Duct Decompression in Hospitalized Acute Decompensated Heart Failure Patients

CRT/ICD in LVAD Patients

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Conduction System Pacing vs CRT in HF

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Early feasibility study of a prototype device to non-invasively measure cardiac and pulmonary vascular pressures

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

How to Manage VT in Advanced HF and Post-LVAD Patients

Cardiac Contractility Modulation

Overview: Growing Role of EP-HF Collaboration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content